0000950170-23-009170.txt : 20230322
0000950170-23-009170.hdr.sgml : 20230322
20230322160650
ACCESSION NUMBER: 0000950170-23-009170
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230320
FILED AS OF DATE: 20230322
DATE AS OF CHANGE: 20230322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tereau Daniel R
CENTRAL INDEX KEY: 0001665985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05075
FILM NUMBER: 23752977
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
STREET 2: PERKINELMER
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PERKINELMER INC
CENTRAL INDEX KEY: 0000031791
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 042052042
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1229
BUSINESS ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-663-5791
MAIL ADDRESS:
STREET 1: 940 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: EG&G INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: EDGERTON GERMESHAUSEN & GRIER INC
DATE OF NAME CHANGE: 19670626
4
1
ownership.xml
4
X0407
4
2023-03-20
false
0000031791
PERKINELMER INC
PKI
0001665985
Tereau Daniel R
940 WINTER STREET
WALTHAM
MA
02451
false
true
false
false
Please See Remarks
false
Common Stock
2023-03-20
4
M
false
3750
52.65
A
22352
D
Common Stock
2023-03-20
4
S
false
15
121.69
D
22337
D
Common Stock
2023-03-20
4
S
false
5122
123.37
D
17215
D
Common Stock
2023-03-20
4
S
false
5304
124.01
D
11911
D
Common Stock
2023-03-20
4
S
false
300
124.79
D
11611
D
NQ Stock Option (right to buy)
52.65
2023-03-20
4
M
false
3750
0
D
2024-02-07
Common Stock
3750
0
D
The Exercise Price included on the Form 4 filed on February 8, 2017 for the Reporting Person was incorrectly reported due to administrative error.
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Tereau on February 16, 2023.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $121.66 to $121.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $122.74 to $123.72. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $123.74 to $124.73. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $124.74 to $124.81. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted.
Senior Vice President, Strategy and Business Development
/s/ John L. Healy (POA on file) for Daniel R. Tereau
2023-03-22